Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics Spectra BioPhotonics EuroPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook

EM Imaging Licenses Fluorescence Imaging Agent for Cancer Detection

Facebook Twitter LinkedIn Email Comments
Edinburgh Molecular Imaging Ltd. (EM Imaging) has signed an exclusive global license with GE Healthcare Ltd. and Dyax Inc. for development of a novel fluorescence imaging agent that could improve the detection of early stage colorectal cancer. In a scientific study published by Nature Medicine (doi: 10.1038/nm.3641), the EMI-137 imaging agent allowed doctors to see more early stage colorectal cancer and precancerous tumors that could be removed via colonoscopy. Colonoscope screenings, the most common method, can miss up to 25 percent of precancerous growths, especially small, flat...Read full article

Related content from Photonics Media



    ARTICLES


    PRODUCTS


    PHOTONICS HANDBOOK ARTICLES


    WHITEPAPERS


    WEBINARS


    PHOTONICS DICTIONARY TERMS


    MEDIA


    PHOTONICS BUYERS' GUIDE CATEGORIES


    COMPANIES

    back to top
    Facebook Twitter Instagram LinkedIn YouTube RSS
    ©2020 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, [email protected]

    Photonics Media, Laurin Publishing
    x Subscribe to BioPhotonics magazine - FREE!
    We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.